Hybrid Argon Plasma Coagulation for Treatment of Gastric Intestinal Metaplasia

Hybrid argon plasma coagulation (HybridAPC® [HAPC]) is an evolution of the standard argon plasma coagulation (APC) technology, where the application of APC is preceded by high-pressure needleless submucosal injection. APC is indicated for the ablation of benign and dysplastic mucosal lesions, such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Estifan, Elias, Cavanagh, Yana, Grossman, Matthew A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182158/
https://www.ncbi.nlm.nih.gov/pubmed/32337147
http://dx.doi.org/10.7759/cureus.7427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182158/
https://www.ncbi.nlm.nih.gov/pubmed/32337147
http://dx.doi.org/10.7759/cureus.7427

Ejemplares similares